Skip to content

Medical emergency? What to do

Agent Shows Ability to Suppress Brain Metastasis and Related Damage

3-RXPublished January 7, 20123 min read

Key points

  • Scientists are one step closer to repairing the damage caused by brain metastasis, a major challenge in cancer treatment, according to data published in Cancer Research, a journal of the American Association for Cancer Research.
  • Steeg, who is also a deputy editor of Clinical Cancer Research, another journal of the AACR, said very few drugs that are effective for the treatment of breast cancer break what scientists call the “blood–brain barrier” and treat disease established inside the brain.
  • Steeg and colleagues observed the role of pigment epithelium-derived factor (PEDF) on metastatic breast cancer cell lines.
  • Although further research is needed to confirm these findings and their applicability, Steeg said the findings represent a significant step forward in trying to manage this condition.

Scientists are one step closer to repairing the damage caused by brain metastasis, a major challenge in cancer treatment, according to data published in Cancer Research, a journal of the American Association for Cancer Research.

“We are making progress from the neck down in cancer treatment, but brain metastases are increasing and are often a primary reason patients with breast cancer do not survive,” said Patricia S. Steeg, Ph.D., head of the Women’s Cancers Section at the National Cancer Institute’s Center for Cancer Research.

Steeg, who is also a deputy editor of Clinical Cancer Research, another journal of the AACR, said very few drugs that are effective for the treatment of breast cancer break what scientists call the “blood–brain barrier” and treat disease established inside the brain.

Scientists are striving to understand the mechanisms and effects of brain cancer metastasis.

Steeg and colleagues observed the role of pigment epithelium-derived factor (PEDF) on metastatic breast cancer cell lines. PEDF is currently being studied as a therapy for macular degeneration because it has been shown to protect neurons in the retina.

Researchers found that PEDF managed to suppress the brain metastatic activity of these lines. Furthermore, it exerted a prosurvival effect on neurons and shielded the brain from tumor-induced damage. Specifically, there was a 3.5-fold reduction in the number of dying neurons adjacent to tumors expressing PEDF.

Although further research is needed to confirm these findings and their applicability, Steeg said the findings represent a significant step forward in trying to manage this condition.

This study was supported by the intramural research programs of the National Cancer Institute and the National Eye Institute and by the U.S. Department of Defense Breast Cancer Research Program.

The mission of the American Association for Cancer Research is to prevent and cure cancer. Founded in 1907, the AACR is the world’s oldest and largest professional organization dedicated to advancing cancer research. The membership includes 33,000 basic, translational and clinical researchers; health care professionals; and cancer survivors and advocates in the United States and more than 90 other countries. The AACR marshals the full spectrum of expertise from the cancer community to accelerate progress in the prevention, diagnosis and treatment of cancer through high-quality scientific and educational programs. It funds innovative, meritorious research grants, research fellowships and career development awards. The AACR Annual Meeting attracts more than 18,000 participants who share the latest discoveries and developments in the field. Special conferences throughout the year present novel data across a wide variety of topics in cancer research, treatment and patient care. The AACR publishes seven major peer-reviewed journals: Cancer Discovery; Cancer Research; Clinical Cancer Research; Cancer Epidemiology, Biomarkers & Prevention; Molecular Cancer Therapeutics; Molecular Cancer Research; and Cancer Prevention Research. AACR journals received 20 percent of the total number of citations given to oncology journals in 2010. The AACR also publishes Cancer Today, a magazine for cancer patients, survivors and their caregivers which provides practical knowledge and new hope for cancer survivors. A major goal of the AACR is to educate the general public and policymakers about the value of cancer research in improving public health, the vital importance of increases in sustained funding for cancer research and biomedical science, and the need for national policies that foster innovation and the acceleration of progress against the 200 diseases we call cancer.

###

Source: American Association for Cancer Research (AACR)

The content on this site is for information only and is not a substitute for professional medical advice, diagnosis or treatment. Drug information pages are an archive and may be out of date: always follow your prescriber, your pharmacist and the current product label. In an emergency, call 911.

Filed underBrainCancer

Keep reading

Cancer

2 views are better than 1 in 3-D breast screening

One view 3D breast screening (tomosynthesis) means less radiation dose and about five seconds less compression, but a study from Yale University, New Haven, CT, found that obtaining both views is necessary to help…

1 min read

When to get help

Reading is for later. These need care now.

Call 911 or go to an emergency department if you or someone with you has any of these:

  • Chest pain or pressureEspecially with breathlessness, sweating or pain in the arm, jaw or back. It can be a heart attack.
  • Face drooping, arm weakness, slurred speechSigns of a stroke. Note the time they started: treatment works best within hours.
  • Severe trouble breathingIncluding a severe allergic reaction with swelling of the lips, tongue or throat.
  • Thoughts of suicideCall or text 988 (Suicide & Crisis Lifeline, US) any time, day or night.

Outside the US, call your local emergency number.

See a doctor within days

  1. 01A new lump, or a sore that does not healMost lumps are harmless, but anything that grows or lasts more than a few weeks should be checked.
  2. 02Unexplained weight loss or lasting fatigueLosing weight without trying, or tiredness that does not lift, can have many causes worth finding.
  3. 03A new medicine and new symptomsSide effects and interactions are common. Ask your pharmacist or prescriber before you stop anything.

General guidance only. If you are unsure how urgent a symptom is, call your doctor or a nurse advice line.